News Update

Govt annonces Padma Awards - Padma Vibhushan to former Japanese PM Shinzo Abe + S P Balasubramaianm + Dr Belle M Hegde + Sudarshan Sahoo + Padma Bhushan to 10 persons including Tarun Gogoi + Sumitra Mahajan + Nripendra Misra + Ram Vilas Paswan + Keshubahi Patel + Padma Shri to 102 persons of repute26 personnel of CBIC get Presidential Awards; Commissioners C P S Bakshi + G Machunlung + Amitesh Bharat Singh + S Thirunavukkarasu also figure in ListCOVID-19 - Global tally about to touch 10 Crore mark + UK’s death count inches close to 100,000GSI to complete 'ambitious' national-level surveys by 2024GST - Provisional attachment of bank account cannot continue where attachment period u/s 83(2) of the CGST Act has lapsed: HCPresident gives nod to Jeevan Raksha Padak awards for 40 personsGST - Confiscation of goods - High Court cannot intervene at SCN stage - assessee directed to file reply to SCN & appear for hearing: HCGST - Provisional attachment of petitioner's cash credit bank account, u/s 74 of SGST Act, is unsustainable; stands lifted: HCKochi Customs seizes FC worth Rs 1.3 Cr and IC worth Rs 45 lakhsWhy Opt for IndusInd Bank Savings Account?Centre releases 13th instalment of Rs 6,000Cr to meet GST shortfallWhetting the budget (App)etiteI-T - Addition on account of revised capital gain under Sec 50C cannot be added to assessee's income, even when his revision petition is barred by limitation : HCCompensation received from municipality for cutting of trees to make way for electrical wires, forms part of assessee's trading operations where such trees were used for generating essential oils & sale thereof - Such compensation received qualifies as agri income & is non taxable: ITATMexican President is latest to test positive for CoronavirusIndia reports 13,203 fresh COVID-19 cases, 131 deathsGrant of registration & issue of assessment or exemption u/s 11 are separate & distinct & process of registration u/s 12AA cannot be made an occasion for deciding upon eligibility for exemption u/s 11: ITATAssessment order is unsustainable where based solely on third party's statements taken behind assessee's back & without permitting cross examination of the deponent: ITATCentre allocates addl Rs 660 Cr to MP for capital projectsAppeal merits re-consideration where dismissed in limine without hearing the assessee: ITATIGI Airport Customs nabs Ugandans with heroin worth Rs 68 CrCX - No reversal of Cenvat credit is warranted u/r 6(3)(b) of CCR 2004 upon removal of Spent Sulphuric Acid: CESTAT
 
COVID-19 Vaccine - PM visits manufacturing plants; praise scientists for exemplary work

By TIOL News Service

NEW DELHI, NOV 29, 2020: THE Prime Minister, Mr Narendra Modi, yesterday undertook a three city tour to conduct extensive review of the vaccine development and manufacturing process. He visited the Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad and Serum Institute of India in Pune.

The scientists expressed joy that the Prime Minister met them face to face in order to boost their morale and help accelerate their efforts at this critical juncture in the vaccine development journey. Prime Minister expressed pride in the fact that India's indigenous vaccine development has progressed at such a rapid pace so far. He spoke on how India is following sound principles of science in the entire journey of vaccine development, while also asking for suggestions to make the vaccine distribution process better.

Prime Minister stressed that India considers vaccines as not only vital to good health but also as a global good, and it is India's duty to assist other countries, including the nations in the neighbourhood, in the collective fight against the virus.

He asked the scientists to express their free and frank opinion on how the country could further improve its regulatory process. The scientists also presented an overview of how they are also developing various new and repurposed drugs to better fight COVID-19.

Upon his visit to Zydus Biotech Park in Ahmedabad, the Prime Minister said, "Visited the Zydus Biotech Park in Ahmedabad to know more about the indigenous DNA based vaccine being developed by Zydus Cadila. I compliment the team behind this effort for their work. Government of India is actively working with them to support them in this journey."

After undertaking the visit to Bharat Biotech facility in Hyderabad, the Prime Minister said, "At the Bharat Biotech facility in Hyderabad, was briefed about their indigenous COVID-19 vaccine. Congratulated the scientists for their progress in the trials so far. Their team is closely working with ICMR to facilitate speedy progress."

After visiting the Serum Institute, the Prime Minister tweeted, "Had a good interaction with the team at Serum Institute of India. They shared details about their progress so far on how they plan to further ramp up vaccine manufacturing. Also took a look at their manufacturing facility."


POST YOUR COMMENTS